Azatricyclic Inverse Agonists of RORγt That Demonstrate Efficacy in Models of Rheumatoid Arthritis and Psoriasis.

Publication

Citation
Liu Q, Xiao HY, Batt DG, Xiao Z, Zhu Y, Yang MG, Li N, Yip S, Li P, Sun D, Wu DR, Ruzanov M, Sack JS, Weigelt CA, Wang J, Li S, Shuster DJ, Xie JH, Song Y, Sherry T, Obermeier MT, Fura A, Stefanski K, Cornelius G, Chacko S, Khandelwal P, Dudhgaonkar S, Rudra A, Nagar J, Murali V, Govindarajan A, Denton R, Zhao Q, Meanwell NA, Borzilleri R, Dhar TGM.: Azatricyclic Inverse Agonists of RORγt That Demonstrate Efficacy in Models of Rheumatoid Arthritis and Psoriasis. ACS Med Chem Lett, Volume 12 (5), 2021
Authors
Batt DG, Borzilleri R, Chacko S, Cornelius G, Denton R, Dhar TGM., Dudhgaonkar S, Fura A, Govindarajan A, Khandelwal P, Li N, Li P, Li S, Liu Q, Meanwell NA, Murali V, Nagar J, Obermeier MT, Rudra A, Ruzanov M, Sack JS, Sherry T, Shuster DJ, Song Y, Stefanski K, Sun D, Wang J, Weigelt CA, Wu DR, Xiao HY, Xiao Z, Xie JH, Yang MG, Yip S, Zhao Q, Zhu Y
Journal
ACS Med Chem Lett
Year
2021
PubMed
34055233
Machine-readable
REST APIRDF
Palacky University Olomouc

Palacky University Olomouc

Faculty of Science

Department of Physical Chemistry

tř. 17. listopadu 1192/12

771 46 Olomouc

Czech Republic

How to cite?

Juračka J., Šrejber M., Melíková M., Bazgier V., Berka K.: MolMeDB: Molecules on Membranes Database. Database, Volume 2019, 2019, baz078, https://doi.org/10.1093/database/baz078

Follow us

FacebookGithub

Financial Support

  • MolMeDB interoperability with UniProt and SwissLipids – MEYS Czech-Swiss project ELIXIR-IMPACT 8K0208 (2026–2028)
ELIXIRGAČRUP Olomouc